Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.69 +0.03 (+4.00%)
As of: Nov 12, 2026 · 12:12 PM EST

Milestone Pharmaceuticals (MIST) Cost of Revenue (2026)

Updated

Analysis

Milestone Pharmaceuticals (MIST) Cost of Revenue (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 Milestone Pharmaceuticals 82.17 Mn -88.43 Mn 527,000.00 32,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32,000.00
Mar 31, 2026 14,000.00
API Access

Milestone Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=MIST&period=max&api_key=YOUR_API_KEY